Life Science R & D Expenditures:
18th Ranked = $650,484,000
NIH Funding: $400,878,894
The Altman Clinical and Translational Research Institute Building recently opened at UCSD. The initial five year $37.2 million grant was renewed with a $52 million grant last year.
In 2015, UCSD researchers were awarded a five year, $30 million grant from the NIH under its new 4D Nucleome Program to explore the role of DNA inside the nucleus in 4 dimensions.
The NIH awarded UC San Diego $13 million over five years to develop and test new stem cell treatments focused on autism and other mental health diseases.
A five year, $9.5 million NIH grant will fund UCSD research into "superbug" antibiotic resistance.
UCSD has started construction on their new Biological and Physical Sciences building, funded in part by a $2 million donation from the Kavli family. This building will include classrooms and laboratories and will focus on brain activity mapping, advanced energy and drug discovery innovation.
A $6.3 million grant was given to a research team from the University of California, San Diego School of Medicine and University of California, Davis to pursue a novel human embryonic stem cell-based therapy to restore damage caused by ALS.
Researchers at the UCSD School of Medicine received more than $5 million in grants to fund research on type 1 diabetes.
Want more recent UCSD funding sts? Click below:
Looking for 10 More Reasons to target the San Diego Research Marketplace - review these 10 blogs
- UCSD Research Funding: Nearly $1M Received for Microbiome Research
- UCSD Science Solutions: $9.5M for Superbug Research
- Lab Suppliers invited to meet Researchers at UCSD's "Big Show"
- CA Researchers - Find Lab Supplies at Upcoming 2016 Product Faire Events
- Network with 1000+ California Life Scientists
- University of California Strengthens Cancer Research with Creation of New 5-School Consortiu
- Biomedical Research and Medical Building News at UCSD
- UCSD Receives $30M from NIH for 4D Nucleome Research
Get Science Market Updates Free when you subscribe via the button below: